Thomas Mika Email & Phone Number

Toronto, Ontario, Ca

POET’s Optical Interposer facilitates the co-packaging of electronics and optics in a single Multi-Chip Module (MCM), paving the way for “Photonics-in-a-package”. Based on our dielectric waveguide technology, the Optical Interposer provides the ability to run electrical and optical interconnections side-by-side on the same interposer chip at a micrometer scale. Hybrid Integrated Photonics Packaging (HiPP) enabled by the Optical Interposer plays a critical role in improving electrical and thermal performance, power consumption and form factor of photonics sub-assemblies. The Optical Interposer currently forms an integral part of POET’s hybrid integrated optical engines and leverages the manufacturing processes and unique capabilities of its dielectric waveguides. More information may be obtained at www.poet-technologies.com.

NanoVibronix is a medical device company focusing on noninvasive biological response-activating devices that target wound healing and pain therapy and can be administered at home, without the assistance of medical professionals. Our WoundShield, PainShield and UroShield products are backed by novel technology which relates to ultrasound delivery through surface acoustic waves.

West Palm Beach, Fl, Us

Rennova Health, Inc. (NASDAQ: RNVA) is a vertically integrated Public Company that provides industry leading Diagnostics and supportive software solutions to healthcare providers. Rennova recognizes that modern healthcare requires a combination of technology and diagnostics to deliver an efficient and effective patient experience and superior clinical outcome. Rennova will continue bringing innovation to healthcare providers and deliver a single source solution through an ever-expanding group of strategic brands that work in unison to empower customers and drive growth. CollabRx, Inc. is a wholly-owned subsidiary of Rennova Health, Inc.

CollabRx, Inc. (NASDAQ: CLRX) CollabRx, Inc. developed and marketed medical information and clinical decision support products and services intended to set a standard for the clinical interpretation of genomics-based, precision medicine. The company was focused on the area of the most critical need - advanced cancer patients who have progressed beyond the standard of care.Building on a comprehensive and specialized knowledge base, software systems that facilitate dynamic updating and automated reporting, and a large network of expert clinical advisors, we developed a suite of unique and differentiated information products and services. These products include a scalable system for providing high-value information on biomarkers and related therapies for inclusion in reports prepared by diagnostic labs reporting on the results from their multi-biomarker genomic-based tests.The Company was merged with Rennova Health, Inc. on November 2, 2016.

Sequel Power promoted, developed and managed major solar energy projects in the U.S. and abroad, particularly in South America and Saudi Arabia.

Petaluma, Ca, Us

Tegal Corporation was a pioneer in the semiconductor capital equipment industry. Founded in 1972 and acquired by Motorola in 1978, the company was spun-out as an independent company in 1990, and went public on the NASDAQ in 1995. Throughout the 1990's and 2000's the industry became increasingly concentrated, with semiconductor companies relying on capital equipment suppliers for most of their product and process development. Although recognized as an innovative company with enabling technology, Tegal was competitively disadvantaged in a market that placed a high value on size and scale. Several acquisitions in the early 2000's were made to increase Tegal's scale and diversify its product-lines. Taking over as CEO in 2005, I terminated several of these acquisitions, restructured operations and acquired a division of Alcatel-Lucent, eventually almost tripling the company's revenue and turning it profitable in 2007. Ultimately, however, these efforts succumbed to the financial crisis in 2008/09. The Board made the decision to divest the company of its product and intellectual property assets and to pursue emerging technologies in other fields. In 2012, Tegal acquired CollabRx, Inc., a private company, changed its name to CollabRx, Inc. in September 2012, and adopted the mission and goals of CollabRx in the health care / bioinformatics industries.

Petaluma, Ca, Us

As EVP and Chief Financial Officer: - Completed 3 company acquisitions, including Sputtered Films, Inc., First Derivative Systems, Inc. and Simplus Systems, Inc.; - Raised $60M+ in private/public financings; - Successfully pursued complex trade secret litigation against Agilent Technologies, Inc. (later Avago Technologies, Ltd.) over 3 years; and - Managed all aspects of corporate finance and reporting as a NASDAQ-listed public company.

IMTEC was a boutique investment firm that operated from 1982 until the early 2000's. We concluded multiple private equity financings, joint ventures, acquisitions and license agreements on behalf of clients in the health care, pharmaceuticals, media and information technology industries. In addition, when required, we took top management positions in companies in which we founded or invested, including DISC International, Inc. (a software company) and Soupmasters International, Inc. (a chain of quick-service mall-based restaurants).

Major assignments included Ciba-Geigy Pharmaceuticals Division, US and Global; Ciba-Geigy Konzern Leitung, Basel, Switzerland; UNY Co., Ltd., Nagoya, Japan; Diamond International, Inc., diversified operations, New York, NY

Deerfield, Illinois, Us

Alexandria, Va, Us

Member of the initial 3-person Science Indicators Unit of the National Science Board. Helped to conceive and write "Science Indicators", the bi-annual report of the National Science Board to the President. Developed new benchmark indicators of the state of industrial R&D in the USA versus other countries.

Mba

Bs, Microbiology, Organic Chemistry, Applied Violin